Business news with perspective

After a costly transformation including the 'Amazon glide down,' UPS posts strong adjusted Q2 profits and raises guidance, proving its pivot to higher-margin business is working.

Singapore's EUDA Health is moving from wellness products to pioneering 'off-the-shelf' cell therapies for cancer, a risky but potentially transformative leap.

With $26M in new funding, Epitel is scaling its wireless, AI-powered EEG system, aiming to revolutionize seizure diagnosis and bridge a critical care gap.

A Florida nonprofit's national spotlight isn't just a lucky break. It's a case study in a new strategic playbook where digital megastars transform local charities into global assets.

As global temperatures rise, international buyers are rewriting the rules of trade. The Canton Fair reveals a new mandate: innovation for a warmer world.

Lowcountry Male & Aqua Vitae's 10th clinic in 10 years isn't just growth; it's a case study in the shift from reactive medicine to personalized wellness.

UTI Investments taps a seasoned distribution leader to spearhead its UK growth, betting his deep network can unlock British capital for India's booming economy.

Vlado Spasov's Trimontium isn't just hiring a lawyer; it's embedding a strategic weapon. The appointment of Graham Morrison signals a new model for speed and complexity in the booming private credit market.

In a market plagued by scams, one dealer's move for BBB accreditation highlights a larger industry push for verifiable trust in precious metals and IRAs.

Data center titan Josh Joshi joins Rubix, a new player with a massive 8GW+ plan. Is this the move that will redefine the AI infrastructure arms race?

A 49% stock plunge and a major acquisition write-down have thrust GeneDx into legal turmoil. We deconstruct the securities fraud claims and what they reveal.

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

As AI reshapes construction, Revizto bets that control, not just capability, is key. Its new platform lets firms use any AI but keeps data safely in-house.

A class-action lawsuit against Futu Holdings exposes the severe risks of China's regulatory crackdown on tech, leaving investors to navigate the fallout.

ADMA Biologics reported 20% growth, but a lawsuit alleges it was a sham built on channel stuffing and hidden deals. Here's what investors need to know.

On World Lung Cancer Day, a $400,000 investment isn't just funding research; it's backing a new generation of scientists tackling the disease's biggest challenges.

Turkish tire giant Lassa is making an aggressive play for Europe with a new line of 'EV ready' tires, signaling a major strategic shift in the global market.

In an era of inevitable breaches, the mechanics of power are shifting from prevention to resilience. A look at the partnerships defining the new cyber battleground.

Fintech firm BiyaPay promises to unite stocks, crypto, and payments into one global account. But as it expands, can it overcome immense hurdles and rising user concerns over fund access?